Asia-Pacific (APAC) recorded a slowdown in transaction activity in 2025, with the total number of announced deals across mergers and acquisitions (M&A), private equity, and venture financing down 3% from the previous year, according to GlobalData. The decline aligns with a more cautious approach to capital deployment across the region, even as some markets recorded growth. “Deal activity was generally softer in most of the APAC markets, highlighting a broader regional pullback in line with the global trend amid uncertain market conditions. However, there were also pockets of growth, reflecting a selective risk appetite amid macro uncertainty and tighter financing conditions,” said Aurojyoti Bose, lead analyst at GlobalData. For insurers, brokers, and investors, the figures point to a more measured pace of dealmaking in 2025, with greater attention to strategic fit, risk, and capital use.
China and India were among the few APAC markets to post an increase in deal volume. GlobalData reported that the number of deals in China rose 5% in 2025 compared with 2024, while India recorded a 6% increase. Hong Kong and Vietnam also registered higher deal counts over the year. Activity in these markets suggests that local and regional investors continue to pursue transactions where pipelines remain active and growth prospects are viewed as durable. For insurance groups, this could mean sustained interest in life and health businesses, general insurance, and specialty lines, intermediaries, bancassurance arrangements, and technology-focused entities in those countries. By contrast, several other APAC markets saw declines. Japan’s deal volume fell 5% year on year, Australia 7%, South Korea 26%, Singapore 11%, and Malaysia 19%. For insurance-focused acquirers and sellers, these trends may correspond with longer transaction timetables, more extensive internal and regulatory review, and tighter scrutiny of capital deployment in those jurisdictions.
GlobalData’s analysis of its Deals Database shows differing patterns across deal types in APAC. Venture financing activity in the region was broadly unchanged in 2025 versus 2024, as investors continued to back companies in technology and innovation while applying stricter requirements on valuation and profitability. This is relevant for insurers and intermediaries working with insurtechs and data or analytics providers. Funding is still available, but investors appear to be more selective about business models and cash flow prospects.
In contrast, corporate and sponsor-backed deals pulled back more sharply. The number of M&A deals announced in APAC fell 5% in 2025, indicating that consolidation and portfolio changes continued but at a slower rate. Private equity deal volume declined 22%, suggesting that financial sponsors are approaching opportunities more cautiously, with higher return expectations and closer assessment of downside risk when considering insurance and adjacent targets.
The APAC numbers form part of a wider global contraction in deal activity. Worldwide, the total number of announced M&A, private equity, and venture financing deals fell 4% in 2025 compared with 2024, GlobalData said. “The downward trajectory across all the deal types signals a potential recalibration of strategies in response to economic uncertainties and shifting market dynamics. The contraction in M&A volume mirrors intensive due diligence by acquirers. The decline in private equity and venture financing activity suggests tightening capital availability and indicates a shift towards more cautious investment strategies. Investors are becoming increasingly selective, focusing on quality over quantity,” Bose said. Globally, M&A deal volume declined 4%, venture financing deals fell 3%, and private equity deals were down 12% over the year. For multinational insurance groups and cross-border investors, the environment is influencing which regions and business lines to prioritise, and where to delay or scale back activity.
GlobalData’s regional breakdown highlights variations that insurance executives and corporate development teams may need to incorporate into planning. North America, still the largest region by deal volume, posted an estimated 1% decline in 2025. Europe saw an 8% contraction, linked to geopolitical and economic pressures. The Middle East and Africa recorded a 7% drop in deals, while South and Central America fell 4%.
APAC’s 3% decline places it between North America and Europe, with growth in China and India helping to offset softer activity in Japan, Australia, South Korea, and other markets. At the country level, the US was largely unchanged in total deal volume. China and India recorded growth of 5% and 6%, respectively, while the UK, Japan, Canada, Germany, Australia, France, and South Korea posted declines of 11%, 5%, 8%, 8%, 7%, 3%, and 26%.
Bose said these differences underline the need for country-specific approaches. “These disparities across key markets highlight the importance of localized strategies. While certain markets exhibit resilience, the overall trend suggests that investors are prioritising stability and quality in their deal-making activities,” Bose said. For insurance professionals in Asia, the data indicates that capital remains available but is being allocated more selectively. Deal pipelines are likely to focus on markets and segments where earnings are more predictable, regulations are clearer, and longer-term growth prospects are considered more favourable, rather than on broad-based expansion across all APAC markets.
